Kleanthis G. Xanthopoulos
2011 - Regulus Therapeutics
In 2011, Kleanthis G. Xanthopoulos earned a total compensation of $703.3K as President and Chief Executive Officer at Regulus Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $112,500 |
|---|---|
| Option Awards | $85,622 |
| Salary | $500,000 |
| Other | $5,192 |
| Total | $703,314 |
Xanthopoulos received $500K in salary, accounting for 71% of the total pay in 2011.
Xanthopoulos also received $112.5K in non-equity incentive plan, $85.6K in option awards and $5.2K in other compensation.
Rankings
In 2011, Kleanthis G. Xanthopoulos' compensation ranked 6,917th out of 10,747 executives tracked by ExecPay. In other words, Xanthopoulos earned more than 35.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,917 out of 10,747 | 36th |
Division Manufacturing | 2,518 out of 3,960 | 36th |
Major group Chemicals And Allied Products | 603 out of 1,033 | 42nd |
Industry group Drugs | 407 out of 781 | 48th |
Industry Pharmaceutical Preparations | 321 out of 571 | 44th |
Source: SEC filing on April 30, 2013.
Xanthopoulos' colleagues
We found two more compensation records of executives who worked with Kleanthis G. Xanthopoulos at Regulus Therapeutics in 2011.